Since host T-cells have acquired no immunological tolerance for these neoantigens, MMR-deficient CRC is more likely to be recognized by the immune system, labeled as foreign/dangerous and targeted for destruction. This evidence concerns the gene MRC1 and colorectal carcinoma.